IP Library Granted Patent US 10,154,812
Granted Patent B2
US 10,154,812 · App. 15/219,255 · Granted Dec 18, 2018

System, method, and applications of using the fundamental code unit and brain language

Inventor: Newton Howard (Arlington, VA)
Assignee: Newton Howard
A61B5/4839A61B5/0476A61B5/112A61B5/407A61B5/4082A61B5/4088A61B5/4803A61B5/4824A61M21/02A61N2/006A61N5/0622A61M2021/0027A61M2021/0044A61N2005/1087A61N2007/0026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,154,812
App. No.
15/219,255
Granted
Dec 18, 2018
Kind
B2
Abstract

The present invention relates to a non-invasive system with diagnostic and treatment capacities that use a unified code that is intrinsic to physiological brain function. In an embodiment of the present invention, an approach to the treatment of disorders that supplements existing diagnostic and treatment methods with robust quantitative data analysis are presented. This is achieved by a unification of cognitive and neural phenomena known as the Fundamental Code Unit (FCU), representing identifiable patterns of brain activity at the submolecular, molecular, and cellular levels (intra-brain communications), as well as their manifestations in thought and language (inter-brain communications).

Claims (28)

1. A method for affecting living tissue comprising:

receiving at least one signal from at least one read modality, the signal representing at least one parameter or measurement of living tissue;

computing at least one signal to effect alterations to the living tissue based on the received input signal; and

delivering the at least one computed signal to the living tissue through at least one write modality to effect alterations to the living tissue.

2. The method of claim 1 wherein the at least one read modality comprises: neurotransmitter level and chirality measurement, linguistic analysis, functional magnetic resonance imaging, electroencephalography, deep brain stimulation, audiovisual stimulation, or motion tracking/gait analysis.

3. The method of claim 1 wherein the at least one write modality comprises: protein transduction, electrochemical methods of signaling, neurotransmitter level and chirality regulation, linguistic analysis, transcranial magnetic stimulation, deep brain stimulation, ultrasound signaling, audiovisual stimulation, photonic pathways inside and outside the brain, proton pathways inside and outside the brain.

4. The method of claim 3 wherein the use of photonic pathways inside and outside the brain provides broad regulatory power over neuroplasticity.

5. The method of claim 3 wherein the use of photonic pathways inside and outside the brain provides broad regulatory power over memory function.

6. The method of claim 3 wherein the use of proton pathways inside and outside the brain provides broad regulatory power over neuroplasticity.

7. The method of claim 3 wherein the use of proton pathways inside and outside the brain provides broad regulatory power over memory function.

8. The method of claim 1 wherein the at least one signal is computed using a structural mathematical system.

9. The method of claim 1 wherein the at least one read modality or the at least one write modality comprises ATP and ADP-mediated signaling through neuronal and glial receptors.

10. The method of claim 1 wherein the at least one read modality or the at least one write modality comprises events related to autofluorescence.

11. The method of claim 1 wherein the at least one read modality or the at least one write modality comprises a neuropsin-mediated unary-coded photonic signaling scheme.

12. The method of claim 1 wherein the at least one read modality or the at least one write modality comprises a neuropsin-mediated unary-coded multi-photonic signaling scheme.

13. The method of claim 1 wherein the at least one read modality or the at least one write modality comprises stimulating or decelerating growth of specific cells throughout a body using Deep Cell Stimulation (DCeS).

14. The method of claim 1 wherein the method is used for diagnosis and treatment of neurodegenerative disorders including at least one of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, or for diagnosis and treatment of other disorders.

15. The method of claim 1 wherein the method is used for Pain Detection and Pain Management.

16. A method for interpreting brain patterns and structures comprising:

receiving at least one signal from at least one read modality, the signal representing at least one parameter or measurement of living brain or spinal cord tissue;

detecting normal and deleterious signaling patterns in brain or spinal cord tissue by analyzing the received at least one signal.

17. The method of claim 16 wherein the method is used for diagnosis and treatment of neurodegenerative disorders including at least one of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, or for diagnosis and treatment of other disorders.

18. The method of claim 16 wherein the method is used for Pain Detection and Pain Management.

19. A method for interpreting and manipulating brain signals comprising:

receiving at least one signal from at least one read modality relating to at least one of a photonic pathway, a proton pathway, an electron pathway, and neural coding and signaling mechanisms, the signal representing at least one parameter or measurement of living brain tissue;

analyzing the input signal based on a detailed model of signaling pathways inside the brain to generate at least one signal to be delivered to the brain tissue; and

delivering the at least one signal to the brain tissue using at least one write modality providing broad control over neuroplasticity and memory function.

20. The method of claim 19 wherein the at least one read modality or the at least one write modality comprises ATP and ADP-mediated signaling through neuronal and glial receptors.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2025
From: HOWARD, NEWTON
To: GENESIS INTELLIGENCE, LLC
Reel/Frame 072702/0249 →
Continuity (7)
Continuation 13747448 · Jan 22, 2013
Continuation In Part 13083352 · Apr 8, 2011
Continuation In Part 12880042 · Sep 10, 2010
Provisional Application 61588666 · Jan 20, 2012
Provisional Application 61322158 · Apr 8, 2010
Provisional Application 61241314 · Sep 10, 2009
Related Publication 20170164895A1 · Jun 15, 2017
Cited By (5)
US 12,268,510 US 12,311,180 US 12,337,180 US 12,560,598 US 12,716,892